{"Here": [0], "we": [1, 137, 156], "report": [2], "on": [3], "the": [4, 19, 31, 54, 104, 131, 144, 166, 169, 174, 181], "antibody": [5], "and": [6, 42, 48, 58, 109, 194], "memory": [7, 63], "B": [8, 64], "cell": [9], "responses": [10], "of": [11, 14, 34, 40, 61, 66, 73, 113, 130, 168, 209], "a": [12, 96, 111, 206], "cohort": [13], "20": [15], "volunteers": [16, 36, 68], "who": [17, 75], "received": [18], "Moderna": [20], "(mRNA-1273)": [21], "or": [22, 90, 141, 147], "Pfizer-BioNTech": [23], "(BNT162b2)": [24], "vaccine": [25], "against": [26, 83, 190], "SARS-CoV-21-4.": [27], "Eight": [28], "weeks": [29], "after": [30], "second": [32], "injection": [33], "vaccine,": [35], "showed": [37], "high": [38], "levels": [39], "IgM": [41], "IgG": [43], "anti-SARS-CoV-2": [44], "spike": [45], "protein": [46], "(S)": [47], "receptor-binding-domain": [49], "(RBD)": [50], "binding": [51], "titre.": [52], "Moreover,": [53], "plasma": [55], "neutralizing": [56], "activity": [57, 82], "relative": [59], "numbers": [60], "RBD-specific": [62], "cells": [65], "vaccinated": [67], "were": [69, 153], "equivalent": [70], "to": [71, 200, 204], "those": [72], "individuals": [74], "had": [76], "recovered": [77], "from": [78, 123], "natural": [79], "infection5,6.": [80], "However,": [81, 126], "SARS-CoV-2": [84, 163], "variants": [85], "that": [86, 136, 180, 195], "encode": [87], "E484K-,": [88], "N501Y-": [89], "K417N/E484K/N501-mutant": [91], "S": [92, 164], "was": [93, 139], "reduced": [94, 140], "by": [95, 103, 128, 143, 173], "small-but": [97], "significant-margin.": [98], "The": [99], "monoclonal": [100, 120, 134, 170, 182], "antibodies": [101, 121, 135, 171, 183], "elicited": [102, 172], "vaccines": [105, 197], "potently": [106], "neutralize": [107], "SARS-CoV-2,": [108], "target": [110], "number": [112], "different": [114], "RBD": [115], "epitopes": [116], "in": [117, 165, 184], "common": [118], "with": [119], "isolated": [122], "infected": [124], "donors5-8.": [125], "neutralization": [127], "14": [129], "17": [132], "most-potent": [133], "tested": [138, 189], "abolished": [142], "K417N,": [145], "E484K": [146], "N501Y": [148], "mutation.": [149], "Notably,": [150], "these": [151, 177], "mutations": [152], "selected": [154], "when": [155], "cultured": [157], "recombinant": [158], "vesicular": [159], "stomatitis": [160], "virus": [161], "expressing": [162], "presence": [167], "vaccines.": [175], "Together,": [176], "results": [178], "suggest": [179], "clinical": [185, 210], "use": [186], "should": [187], "be": [188, 201], "newly": [191], "arising": [192], "variants,": [193], "mRNA": [196], "may": [198], "need": [199], "updated": [202], "periodically": [203], "avoid": [205], "potential": [207], "loss": [208], "efficacy.": [211]}